Litigation for RIVASTIGMINE

US Court Litigation for RIVASTIGMINE

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
6,316,023		1:13-cv-00370|D. Del.	2013-03-07	2014-07-07	35:271 Patent Infringement	District Court, D. Delaware	None
6,316,023	Novartis Pharmaceuticals Corporation v. Actavis Inc.	1:13-cv-00371|D. Del.	2013-03-07	2014-08-04	35:271 Patent Infringement	District Court, D. Delaware	None
6,316,023	Novartis Pharmaceuticals Corporation v. Noven Pharmaceuticals Inc.	1:13-cv-00527|D. Del.	2013-04-03	2015-09-14	35:271 Patent Infringement	District Court, D. Delaware	None
6,316,023		1:13-cv-01467|D. Del.	2013-08-22	2014-09-17	35:271 Patent Infringement	District Court, D. Delaware	None
6,316,023	Novartis Pharmaceuticals Corporation v. Noven Pharmaceuticals Inc.	1:14-cv-00111|D. Del.	2014-01-30	2015-09-14	35:271 Patent Infringement	District Court, D. Delaware	None
6,316,023	Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.	1:14-cv-00777|D. Del.	2014-06-19	2015-09-16	35:0145	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for RIVASTIGMINE

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
6,316,023	Noven Pharmaceuticals, Inc. et al.		2014-04-02	04-02-2014	Novartis AG	Inter partes review		10-14-2014	Bodo Asmussen
6,316,023	Mylan Pharmaceuticals Inc. et al.		2014-11-13	11-13-2014	Novartis AG	Inter partes review		04-10-2015	Bodo Asmussen
6,335,031	Noven Pharmaceuticals, Inc. et al.		2014-04-02	04-02-2014	Novartis AG	Inter partes review		10-14-2014	BODO ASMUSSEN
6,335,031	Mylan Pharmaceuticals Inc. et al.		2014-11-13	11-13-2014	Novartis AG	Inter partes review		04-10-2015	BODO ASMUSSEN